CPDA-1


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

citrate

 [sit´rāt, si´trāt]
any anionic form, salt, or ester of citric acid.
citrate phosphate dextrose (CPD) a solution containing citric acid, sodium citrate, monobasic sodium phosphate, and dextrose that is the primary anticoagulant used for preservation of whole blood or red blood cells for up to 21 days. The official USP name is anticoagulant citrate phosphate dextrose solution.
citrate phosphate dextrose adenine (CPDA-1) an anticoagulant solution, containing citric acid, sodium citrate, monobasic sodium phosphate, dextrose, and adenine, used for the preservation of whole blood and red blood cells for up to 35 days; it extends red cell survival by providing adenine needed for the maintenance of red cell ATP levels. The official USP name is anticoagulant citrate phosphate dextrose adenine solution.

CPDA-1

citrate phosphate dextrose adenine; see anticoagulant citrate phosphate dextrose adenine solution, under solution.

CPDA-1

abbreviation for citrate phosphate dextrose adenine.

CPDA-1

Citrate phosphate dextrose-adenine 1. A medium which supplies ATP, and extends the shelf life of packed red cells destined for transfusion to 35 days with a higher ATP level than earlier-generation red cell preservation media.

CPDA-1

citrate-phosphate-dextrose-adenine; an anticoagulant used in blood collection bags.
References in periodicals archive ?
concentration of CPDA-1 RBC at haematocrit of 70 per cent at 35 days of storage (permitted shelf life) will be around 70-80 meq/litre.
The glucose utilization and lactate production were negatively correlated in all the red cell preparations with CPDA-1 RBC having highest lactate concentration on day 21.
Though, whole blood had least biochemical alterations followed by SAGM RBC, but for transfusing the same amount of blood (15 ml/kg) for correcting anaemia, CPDA-1 or SAGM RBC are preferred over whole blood because of higher post-transfusion haemoglobin increment by RBCs as compared to whole blood.
The potassium haemoglobin and acid content of CPDA-1 whole blood, plasma reduced red cells and red cells suspended in SAG-M over 35 days.